Device may reduce liver biopsy rate.(News) From: Internal Medicine News | Date: March 1, 2005| Author: Evans, Jeff | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

A new device for noninvasively measuring liver fibrosis could decrease the number of liver biopsies performed on patients with chronic hepatitis C. especially when used with other noninvasive tests.

The device, called FibroScan, might bring more patients with chronic hepatitis C to a clinic for evaluation of liver fibrosis because the procedure is painless and takes less than 5 minutes, according to two prospective studies.

Liver biopsy is considered the stand...

Related newspaper, magazine, and journal articles from HighBeam Research

	Noninvasive device measures liver fibrosis.(Clinical Rounds) Family Practice News ; A new device for noninvasively measuring liver fibrosis could decrease the number of liver biopsies performed on patients with chronic hepatitis C, especially when it is combined with other noninvasive tests. The device, called FibroScan, might bring more patients with chronic hepatitis C to a
	YOUR PROBLEMS: Lily-livered over surgeon's probe; LETTER OF THE DAY.(Features) The Mirror (London, England) ; Byline: Miriam Stoppard SOME time ago I had a blood test which showed an abnormality of my liver. The consultant wasn't sure what was causing it and has suggested a liver biopsy. What does a this entail and is it dangerous? A LIVER biopsy isn't dangerous and is usually performed as a day case -
	Liver biopsy and screening for cancer in hepatitis C.(Editorials) American Family Physician ; In June of 2002, the National Institutes of Health (NIH) convened a consensus development conference on the management of hepatitis C. (1) This conference differed from a previous conference (2) on management of hepatitis C by including presentations from a detailed systematic review of evidence on
	Biopsy or Biomarkers: Is There a Gold Standard for Diagnosis of Liver Fibrosis? Clinical Chemistry ; Liver biopsy has long been the gold standard for the grading of hepatic inflammation and the staging of hepatic fibrosis, and has been used as the reference standard method in evaluations of plasma markers of liver disease. In the modern era with the use of ultrasound guidance, biopsy is an
	Liver biopsy may become more of a prognostic than diagnostic test.(Digestive Disorders) Family Practice News ; Philadelphia -- Liver biopsy is losing its appeal as a diagnostic tool for chronic liver disease, Dr. K. Rajender Reddy said at the annual meeting of the American College of Physicians. Problems associated with liver biopsy such as sampling error, inadequate specimens, and interobserver variability

See all results.